Company Data
Defence Therapeutics Inc Cl A
Ticker
DTCFF
Current Price
$0.35 11.31%
Market Cap
$20.1M
Price Target
Refer to Report
Volume
100
52wk Range
$0.292 - $0.7787
Overview
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.